High expression of CBX3 is generally associated with a worse prognosis, particularly when it is associated with a low expression of STAT1. Moreover, low expression of CBX3 is indicative of a better prognosis for the majority of CRC patients who exhibit a low expression of CD274. This evidence concerns the gene CD274 and colorectal carcinoma.